SARAH GRGURICH: Open Payments
NPI 1518606771 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$803 in 42 payments from 8 companies in 2025. Trend: 2023 $616 · 2024 $469 · 2025 $803
Food & beverage: $803
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 10 | $241 |
| Ipsen Biopharmaceuticals, Inc | 14 | $236 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $145 |
| Gilead Sciences, Inc. | 4 | $83 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $31 |
| Eton Pharmaceuticals, Inc. | 1 | $24 |
| Intercept Pharmaceuticals, Inc. | 1 | $24 |
| Mirum Pharmaceuticals, Inc. | 1 | $19 |
Products named: REZDIFFRA, IQIRVO, XIFAXAN, LIVTENCITY, GALZIN, OCALIVA, Livmarli.
Industry payments across OK — which companies pay providers there.
